We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+7.53%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.07B
AUM Growth
+$162M
Cap. Flow
+$141M
Cap. Flow %
13.21%
Top 10 Hldgs %
37.33%
Holding
532
New
105
Increased
323
Reduced
47
Closed
36

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$9.31M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$8.32M
3
NVDA icon
NVIDIA
NVDA
+$6.63M
4
MSFT icon
Microsoft
MSFT
+$6.29M
5
UGL icon
ProShares Ultra Gold
UGL
+$5.95M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$5.72M
2
PDD icon
Pinduoduo
PDD
+$4.15M
3
PG icon
Procter & Gamble
PG
+$2.96M
4
SNPS icon
Synopsys
SNPS
+$2.64M
5
AMAT icon
Applied Materials
AMAT
+$2.41M

Sector Composition

Rank Sector Weight
1 Technology 38.03%
2 Healthcare 25.43%
3 Consumer Discretionary 12.38%
4 Communication Services 10.24%
5 Financials 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ETNB
326
DELISTED
89bio
ETNB
$195K 0.02%
24,932
+4,562
+22% +$37.6K
AVXL icon
327
Anavex Life Sciences
AVXL
$316M
$193K 0.02%
17,980
+1,671
+10% +$12.9K
GRFS
328
Grifois
GRFS
$5.4B
$192K 0.02%
25,867
+2,403
+10% +$20.1K
AVBP icon
329
ArriVent BioPharma
AVBP
$1.47B
$190K 0.02%
+7,145
New +$205K
ADPT icon
330
Adaptive Biotechnologies
ADPT
$4.02B
$188K 0.02%
31,292
+2,928
+10% +$16.1K
ALV icon
331
Autoliv
ALV
$8.85B
$188K 0.02%
2,000
– –
GMAB icon
332
Genmab
GMAB
$19.6B
$186K 0.02%
8,891
+827
+10% +$18.2K
PCRX icon
333
Pacira BioSciences
PCRX
$945M
$184K 0.02%
9,790
+918
+10% +$16.1K
ABCL icon
334
AbCellera Biologics
ABCL
$3.18B
$184K 0.02%
62,629
+5,955
+11% +$16.6K
COGT icon
335
Cogent Biosciences
COGT
$6.76B
$183K 0.02%
23,422
+2,371
+11% +$23.6K
MAGS icon
336
Listed Funds Trust Roundhill Magnificent Seven ETF
MAGS
$4.15B
$175K 0.02%
+3,201
New +$164K
KNSA icon
337
Kiniksa Pharmaceuticals
KNSA
$6.1B
$174K 0.02%
8,814
+1,004
+13% +$22.9K
PLRX icon
338
Pliant Therapeutics
PLRX
$66.3M
$170K 0.02%
12,903
+1,209
+10% +$16.5K
LENZ
339
LENZ Therapeutics
LENZ
$158M
$168K 0.02%
+5,831
New +$178K
TGT icon
340
Target
TGT
$69.9B
$167K 0.02%
1,232
-3,120
-72% -$447K
MRVI icon
341
Maravai LifeSciences
MRVI
$861M
$164K 0.02%
30,076
+2,851
+10% +$18.3K
CVAC
342
DELISTED
CureVac
CVAC
$162K 0.02%
47,568
+4,425
+10% +$12.8K
ZTS icon
343
Zoetis
ZTS
$30.4B
$161K 0.02%
986
– –
CSTL icon
344
Castle Biosciences
CSTL
$960M
$158K 0.01%
5,939
+604
+11% +$18.4K
PRTA icon
345
Prothena Corp
PRTA
$475M
$158K 0.01%
11,409
+1,065
+10% +$16.8K
DIA icon
346
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$48.2B
$157K 0.01%
370
+220
+147% +$95.2K
VGT icon
347
Vanguard Information Technology ETF
VGT
$149B
$152K 0.01%
+1,960
New +$151K
XLY icon
348
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.4B
$151K 0.01%
1,344
– –
ERAS icon
349
Erasca
ERAS
$6.45B
$150K 0.01%
59,949
+5,614
+10% +$15.4K
CGEM icon
350
Cullinan Oncology
CGEM
$1.26B
$150K 0.01%
12,346
+1,195
+11% +$17.2K
12 13
14
15 16

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q4 2024 Portfolio in Review

As of Q4 2024, China Universal Asset Management Company held 532 positions worth $1.07B, up 18% from $907M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

China Universal Asset Management Company deployed $141M of net new capital in Q4 2024, opening 105 new positions and adding to 323 existing holdings. Its largest new stake was Astera Labs: 26,000 shares worth $3.44M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 38% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Pinduoduo, an estimated $4.15M trimmed.

  • China Universal Asset Management Company's largest Q4 2024 buy was Astera Labs: 26,000 shares worth $3.44M.
  • China Universal Asset Management Company added most to Apple in Q4 2024, an estimated $9.31M increase.
  • China Universal Asset Management Company's biggest Q4 2024 reduction was Pinduoduo, cutting an estimated $4.15M.
  • China Universal Asset Management Company fully exited Alibaba in Q4 2024, selling an estimated $5.72M.
  • China Universal Asset Management Company's ten largest holdings make up 37% of its $1.07B portfolio in Q4 2024.
  • China Universal Asset Management Company opened 105 new positions and closed 36 in Q4 2024.
  • China Universal Asset Management Company's portfolio value rose 18% quarter-over-quarter to $1.07B.

Based on China Universal Asset Management Company's 13F filing for Q4 2024, filed 24 Jan 2025.